4.6 Article

Defining the epigenetic status of blood cells using a cyanine-based fluorescent probe for PRMT1

期刊

BLOOD ADVANCES
卷 2, 期 21, 页码 2829-2836

出版社

ELSEVIER
DOI: 10.1182/bloodadvances.2018020727

关键词

-

资金

  1. Leukemia Research Foundation
  2. National Cancer Institute, National Institutes of Health [1R21CA202390]
  3. National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health [1R01DK110574, DK100847]
  4. National Institute of General Medical Sciences, National Institutes of Health [R01GM126154]
  5. National Heart, Lung, and Blood Institute, National Institutes of Health [HL092215, HL136165]
  6. Veterans Administration [BX000369, BX003617]
  7. National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health [P30 AR048311]
  8. National Institute of Allergy and Infectious Diseases, National Institutes of Health [P30 AI027667]
  9. NATIONAL CANCER INSTITUTE [R21CA202390] Funding Source: NIH RePORTER
  10. NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092215, R01HL136165] Funding Source: NIH RePORTER
  11. NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR048311] Funding Source: NIH RePORTER
  12. NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK110574, R01DK100847] Funding Source: NIH RePORTER
  13. NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM126154] Funding Source: NIH RePORTER
  14. NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS095626] Funding Source: NIH RePORTER
  15. Veterans Affairs [IK6BX003617, I01BX000369] Funding Source: NIH RePORTER

向作者/读者索取更多资源

Dynamic regulation of histone modification enzymes such as PRMT1 (protein arginine methyltransferase 1) determines the ordered epigenetic transitions in hematopoiesis. Sorting cells according to the expression levels of histone modification enzymes may further define subpopulations in hematopoietic lineages with unique differentiation potentials that are presently defined by surface markers. We discovered a vital near infrared dye, E84, that fluoresces brightly following binding to PRMT1 and excitation with a red laser. The staining intensity as measured by flow cytometry is correlated with the PRMT1 expression level. Importantly, E84 staining has no apparent negative effect on the proliferation of the labeled cells. Given that long-term hematopoietic stem cells (LT-HSCs) produce low levels of PRMT1, we used E84 to sort LT-HSCs from mouse bone marrow. We found that SLAM (the signalling lymphocyte activation molecule family) marker-positive LT-HSCs were enriched in the E84(low) cell fraction. We then performed bone marrow transplantations with E84(high) or E84(low) Lin(-)Sca1(+)Kit(+) (LSK) cells and showed that whole blood cell lineages were successfully reconstituted 16 weeks after transplanting 200 E84(low) LSK cells. Thus, E84 is a useful new tool to probe the role of PRMT1 in hematopoiesis and leukemogenesis. Developing E84 and other small molecules to label histone modification enzymes provides a convenient approach without modifying gene loci to study the interaction between hematopoietic stem/progenitor cell epigenetic status and differentiation state.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据